Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Russian drone, missile attack on Kyiv hits residential buildings
US, Iran talks conclude in Doha, focused on Strait of Hormuz
Kenyan court charges 8 schoolgirls with fellow students' murder
At least 5 people killed in fire in Antwerp apartment block
Three people die in Mexico World Cup celebrations as fans crowd streets
After Venezuela quakes, citizens lead rescues amid military theft accusations
Two dead after wildfire guts house in northern Greece
Afghanistan launches airstrikes on IS targets on border with Pakistan
